Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

LEGGE, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.430
AS - Asia 1.212
EU - Europa 248
AF - Africa 117
SA - Sud America 69
OC - Oceania 2
Totale 3.078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.412
SG - Singapore 701
CN - Cina 374
MA - Marocco 110
DE - Germania 93
BR - Brasile 53
PK - Pakistan 36
IT - Italia 24
VN - Vietnam 24
FR - Francia 23
PL - Polonia 23
HK - Hong Kong 21
GB - Regno Unito 20
NL - Olanda 20
BD - Bangladesh 13
CZ - Repubblica Ceca 11
JP - Giappone 10
IN - India 9
CA - Canada 8
LT - Lituania 6
UA - Ucraina 6
FI - Finlandia 5
MX - Messico 5
SE - Svezia 5
EC - Ecuador 4
ES - Italia 4
ID - Indonesia 4
JM - Giamaica 4
TR - Turchia 4
AR - Argentina 3
EG - Egitto 3
VE - Venezuela 3
ZA - Sudafrica 3
AM - Armenia 2
AZ - Azerbaigian 2
HR - Croazia 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AU - Australia 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PW - Palau 1
PY - Paraguay 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.078
Salva come PNG Salva come JPEG
Città #
San Jose 381
Dallas 355
Singapore 316
Ashburn 251
The Dalles 127
Hefei 121
Casablanca 107
Munich 72
Islamabad 36
Chicago 31
Los Angeles 26
Hillsboro 25
Warsaw 22
Hong Kong 21
New York 18
Council Bluffs 17
Atlanta 16
Amsterdam 14
Frankfurt am Main 13
Beijing 12
Santa Clara 10
Tokyo 10
Boston 9
Brno 9
Ho Chi Minh City 9
London 9
Orem 9
Brooklyn 8
Reston 7
Boydton 6
Phoenix 6
San Francisco 6
São Paulo 6
Chennai 5
Stockholm 5
Bari 4
Milan 4
Ankara 3
Charlotte 3
Clifton 3
Haiphong 3
Marrakesh 3
Paris 3
Poplar 3
Rome 3
Seattle 3
Toronto 3
Turku 3
Baku 2
Barnet 2
Biên Hòa 2
City of London 2
Cuiabá 2
Denver 2
Guayaquil 2
Hanoi 2
Johannesburg 2
Kansas City 2
Kingston 2
Limburg an der Lahn 2
Mexico City 2
Montreal 2
Olomouc 2
St Petersburg 2
Tappahannock 2
Yerevan 2
Zagreb 2
Ahmedabad 1
Alexandria 1
Alfenas 1
Allen 1
Amman 1
Angri 1
Aracruz 1
Arapoti 1
Araxá 1
Arujá 1
Athens 1
Baoding 1
Betânia do Piauí 1
Bismarck 1
Bogotá 1
Botucatu 1
Buenos Aires 1
Cabimas 1
Cabreúva 1
Cairo 1
Calamba 1
Calgary 1
Campinas 1
Can Tho 1
Cape Town 1
Carmópolis de Minas 1
Cascavel 1
Catania 1
Changsha 1
Charleston 1
Ciudad del Este 1
Cochabamba 1
Criciúma 1
Totale 2.207
Salva come PNG Salva come JPEG
Nome #
Biologia e genetica molecolare in ginecologia ed ostetricia 48
Celecoxib modulates the expression of cyclooxygenase-2, Ki67, apoptosis-related marker, and microvessel density in human cervical cancer: A pilot study 47
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 45
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) in patients with advanced ovarian cancer (AOC): final analysis of the MITO-2 randomized multicenter trial 44
Analysis of survivin expression in ovarian cancer and its correlation with clinical, surgical, pathological and apoptosis-related parameters 43
BRCA1-related malignancies in a family presenting with von Recklinghausen's disease 43
Angiogenesis inhibitors in gynecological cancers 42
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III 41
Celecoxib plus carboplatin in heavily pre-treated patients with recurrent ovarian carcinoma: preliminary results of a phase II study 40
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinicopathological parameters 39
Advances in surgical management of cervical cancer 39
[Familial ovarian carcinoma] 39
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: Safety, outcome, and prognostic measures 38
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study 37
[Biological factors with prognostic significance in ovarian cancer]. Fattori biologici con significato prognostico nel cancro ovarico 37
Anatomical distribution of sentinel lymph nodes in patients with endometrial cancer: a multicenter study 37
Biological characterization of ovarian cancer: prognostic and therapeutic implications 36
Celecoxib modulates angiogenesis-related parameters in both sera and tumor biopsies from cervical cancer patients 35
A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients 34
Biologia e genetica molecolare in ginecologia ed ostetricia 34
Whose surgery is this? Endometriosis of the round ligament 33
Tumori maligni della cervice uterina 33
Ruolo dell'isterectomia laparoscopica nel trattamento del carcinoma della cervice uterina 32
Magnetic resonance imaging of pelvic endometriosis. Effect of reader's experience on accuracy and interobserver variability 32
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 32
Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment 32
Tumori maligni della cervice uterina 31
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept 31
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: Clinical considerations 31
Cyclooxygenase-2 (COX-2) inhibition is associated with increased proportion of Tumor Infiltrating Lymphocytes (TIL) expressing the zeta chain of T-Cell Receptor (TCR) in human cervical cancer 31
Cyclooxygenase-2 (COX-2) expression in non neoplastic (NNED) and  neoplastic vulvar epithelial disorders 30
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 30
Targeted therapy for ovarian cancer 29
Transplacental carcinogenesis: state of the art 29
Large-field pre-operative chemoradiation in locally advanced carcinoma of the cervix: preliminary results of a phase I study (LARA-CC-1) 29
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome 29
Cyclooxygenase-2 expression in endometrial carcinoma - Correlation with clinicopathologic parameters and clinical outcome 28
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions 28
Intensified pre-operative chemoradiation in locally advanced carcinoma of the uterine cervix: final resultsof a phase I-II study (ESTER-1) 27
Postoperative concomitant boost radiotherapy in high risk endometrial cancer 27
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 27
Progestin-realising intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 27
Phase II study on Pemetrexed in advanced and/or recurrent cervical cancer patients: a MITO study 27
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer 27
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis 27
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 27
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer 27
Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma 26
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer 26
Indicatori molecolari prognostici e predittivi di risposta nel carcinoma ovarico 26
Targeted therapies in gynecological cancers 26
Il carcinoma ovarico familiare 26
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. 26
The peritoneal cavity: tumor metastasis and growth 26
Nerve-sparing laparoscopic colposacropexy using a percutaneous surgical system: a case report 25
Clinical role of Cyclooxygenase-2 (COX-2) expression in tumor and stromal component of cervical cancer 25
COX-2 inhibition in gynaecological cancers 25
Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer 25
Endometriosis and Cancer 25
Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature 25
Prospettive future per i tumori della cervice uterina 25
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 25
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications 24
Laparoscopic en bloc right diaphragmatic peritonectomy for diaphragmatic endometriosis according to the Sugarbaker technique 24
Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery 24
Verso la classificazione molecolare dei tumori: possibili implicazioni prognostiche e terapeutiche 24
Intensity-modulated extended field chemoradiation plus simultaneous integrated boost in the preoperative treatment of locally advanced cervical cancer: a dose-escalation study 24
Fattori prognostici nel carcinoma ovarico epiteliale 24
Tumori dell'ovaio 24
Expression of surviving in locally advanced cervical cancer (LACC) patients administered chemoradiation (CT/RT) followed by radical surgery (RS): prediction of response and clinical outcome 24
From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer 24
Radical surgery (RS) plus intraperitoneal hyperthermic perfusion (IPHP) with oxaliplatin followed by intravenous docetaxel in the treatment of peritoneal carcinosis from platinum-sensitive recurrent ovarian cancer (OC): A pilot study 24
Proposal of a prognostic score in combined modality treatment of locally advanced carcinoma of the uterine cervix 24
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients 24
Comparison of absorbable and permanent sutures for laparoscopic sacrocervicopexy: A randomized controlled trial 24
Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer 23
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis 23
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: Feasibility and clinical results 23
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters 23
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study 23
Nuovi Fattori Biologici di Prognosi nel Carcinoma dell'Endometrio 23
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B 23
New drugs in ovarian cancer 22
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures 22
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 22
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients 22
Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, modulates cytokines levels in serum of cervical cancer patients 22
New insights in biological characterization of ovarian cancer 22
Which role for pre-treatment laparoscopic staging? 22
Simultaneous integrated boost volumetric modulated Arc therapy in the postoperative treatment of high-risk to intermediate-risk endometrial cancer: results of ADA II phase I-II trial 22
Is there a prognostic role for the pattern of recurrence in platinum-sensitive relapsing ovarian cancer patients? 22
Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects 22
Laparoscopic vs transvaginal cuff closure after total laparoscopic hysterectomy: a randomized trial by the Italian Society of Gynecologic Endoscopy 22
Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer 21
Prognostic factors in clear cell carcinoma of endometrium: analysis of 55 cases 21
Comparison Between Laparoscopic and Robotic Surgery in Elderly Patients With Endometrial Cancer: A Retrospective Multicentric Study 21
Prolonged Chemoradiation in Locally Advanced Carcinoma of the Uterine Cervix Final Results of a Phase II Study (ESTER-1) 21
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome 20
Il tumore ovarico borderline: diagnosi, trattamento, restaging 20
Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective, Phase II Study 20
Totale 2.832
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.941
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.941
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024203 0 0 0 121 9 2 0 1 24 30 4 12
2024/2025659 19 48 40 24 74 2 1 24 193 13 110 111
2025/20262.337 95 371 221 261 55 109 642 227 156 200 0 0
Totale 3.199